Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nortriptyline 10mg tablets
0403010V0AAADAD
|
Nortriptyline | Nortriptyline | Central Nervous System | 86,513 |
|
Nortriptyline 25mg tablets
0403010V0AAAEAE
|
Nortriptyline | Nortriptyline | Central Nervous System | 47,203 |
|
Nortriptyline 50mg tablets
0403010V0AAARAR
|
Nortriptyline | Nortriptyline | Central Nervous System | 7,859 |
|
Nortriptyline 10mg capsules
0403010V0AAAWAW
|
Nortriptyline | Nortriptyline | Central Nervous System | 4,768 |
|
Nortriptyline 25mg capsules
0403010V0AAAXAX
|
Nortriptyline | Nortriptyline | Central Nervous System | 1,276 |
|
Nortriptyline 25mg/5ml oral solution sugar free
0403010V0AAAVAV
|
Nortriptyline | Nortriptyline | Central Nervous System | 49 |
|
Nortriptyline 10mg/5ml oral solution sugar free
0403010V0AAAUAU
|
Nortriptyline | Nortriptyline | Central Nervous System | 33 |
|
Nortriptyline 10mg/5ml oral suspension
0403010V0AAAGAG
|
Nortriptyline | Nortriptyline | Central Nervous System | 12 |
|
Nortriptyline 25mg/5ml oral liquid
0403010V0AAAQAQ
|
Nortriptyline | Nortriptyline | Central Nervous System | 1 |
|
Nortriptyline 10mg / Fluphenazine 500microgram tablets
0403010V0AAAMAM
|
Nortriptyline | Nortriptyline | Central Nervous System | No data available |
|
Nortriptyline 10mg/5ml oral solution
0403010V0AAANAN
|
Nortriptyline | Nortriptyline | Central Nervous System | No data available |
|
Nortriptyline 30mg / Fluphenazine 1.5mg tablets
0403010V0AAALAL
|
Nortriptyline | Nortriptyline | Central Nervous System | No data available |
|
Nortriptyline 50mg/5ml oral solution
0403010V0AAATAT
|
Nortriptyline | Nortriptyline | Central Nervous System | No data available |
|
Nortriptyline 50mg/5ml oral suspension
0403010V0AAASAS
|
Nortriptyline | Nortriptyline | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.